Interim report, May 1, - October 31,1999/2000

· An operating loss of SEK 37 M (loss: 43) was reported. Before items affecting comparability the operating loss was SEK 37 M (loss: 97).

· An operating profit of SEK 20 M was posted for the second quarter.

· Cash flow was positive for the fourth consecutive quarter.

· The sale of IGS and the related winding up measures is estimated to have a favorable impact in the order of SEK 20 M on profit during the third quarter.

· A new share issue with preferential rights for existing shareholders will be implemented during December 1999.

· An incentive program for senior executives is to be introduced in March 2000.

For further information, please contact:
Lars Jonsteg, VP Corporate Relations, Elekta AB (publ). +46 8 587 254 82

Elekta

Elekta is a leading international medical-technology company offering advanced and innovative clinical solutions and services for precision radiation treatment of cancer and minimally invasive treatment of brain disorder...

View more


  CONTACT  
  • Stina Thorman
  • Vice President Corporate Communications
  • +46 8 587 254 37
  •  

Related documents

 
 
 
 
Social Media Pitch:
Interim report, May 1, - October 31,1999/2000